Specialists state that up to 1 in 3 Europeans will suffer at least once in their lifetime from a disease affecting the neurological system. This leads to great human suffering and restricts the independence of those suffering from these diseases as a result of disability and the need for care. The financial and non-financial burden on those affected, their social environment and on health care systems is enormous.
Company's inception year: 2016
KOIS investment year: 2016
Target population: children and adults suffering from neurological and orthopedic disabilities
Nilofar Niazi and Edward Schiettecatte gave up their career in the US to start TRAINM, when they found out that the chances that their son, affected by a cerebral palsy, would ever walk, talk or see were close to zero.
TRAINM is an outpatient neuro-rehabilitation clinic for children and adults with a broad range of neurological and orthopaedic disabilities, such as stroke, multiple sclerosis and Parkinson. Therapy is based on neuroplasticity, reducing neurological deficits from injuries to the brain and spinal cord. Patients receive on average 1,000 movements per session, 20 times more than conventional physical therapy.
Therapies include personalised high intensity therapies, coupled with non-invasive brain stimulation, neuro-technology, virtual reality, neuro gaming, artificial intelligence and robotics. Patients who do not have the financial means to receive outpatient treatment at TRAINM may be eligible to receive assistance from the TRAINM Foundation.
In 2016, KOIS invested in TRAINM because of its potential to offer life-changing therapy to people who otherwise would not have a viable chance of recovery. Initiatives like TRAINM bridge the gap between discoveries made in research laboratories and the patients’ needs.
TRAINM's impact in 2019
9000 + robotics sessions
1000+ neuro-modulation sessions
For more info on TRAINM; visit https://trainm.com/
Sources: European Brain Council, Institut de la Moëlle Epinière; EAN, Amsterdam 2017, Neurological diseases on the rise: European collaboration in research essential; De Tijd, 7 november 2017